| HOME >> BIOLOGY >> TECHNOLOGY |
Long-term investments 24,668 -
Other noncurrent assets 1,451 1,441
Total assets $160,334 $149,844
Liabilities and stockholders' equity:
Accounts payable and accrued expenses $22,779 $20,790
Amounts due to related parties 4,513 2,311
Deferred revenue 3,199 3,939
Capital lease obligations 472 485
Total current liabilities 30,963 27,525
Capital lease obligations, net of current
portion 689 794
Deferred revenue, net of current portion 473 421
Other long-term liabilities 240 226
Total stockholders' equity 127,969 120,878
Total liabilities and stockholders' equity $160,334 $149,844
To supplement our consolidated financial statements presented in
accordance with GAAP, Cynosure uses the following measures defined as
non-GAAP financial measures by the SEC: non-GAAP gross profit, non-GAAP
income from operations, non-GAAP net income and non-GAAP diluted earnings
per share. The presentation of this financial information is not intended
to be considered in isolation or as a substitute for the financial
information prepared and presented in accordance with GAAP. In addition,
the non-GAAP financial measures included in this press release may be
different from, and therefore not comparable to, similar measures used by
other companies. Although certain non-GAAP financial measures used in this
release exclude the accounting
'/>"/>
| SOURCE Cynosure, Inc. Copyright©2008 PR Newswire. All rights reserved |